Nasus Pharma layoffs, on the record
Every job cut, severance charge and restructuring Nasus Pharma reported in its annual reports, 2025, quoted from the filings.
Job cuts, severance and restructuring
None of Nasus Pharma’s annual reports for 2025 describes a layoff, workforce reduction or restructuring.
| Fiscal year ended | Severance costs |
|---|---|
| 2023-12-31 | $10,000 |
| 2024-12-31 | $10,000 |
| 2025-12-31 | $32,000 |
Nasus Pharma has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Nasus Pharma’s annual reports (20-F for 2025) and the financial data it files with the SEC, as of 2026-03-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.